HONOLULU — Researchers in Hawaii are involved in the development of a drug they hope will one day be available to treat Alzheimer’s Disease. The drug is now in clinical trial and patients don’t even have to leave their homes to participate. Millions of people in the U.S. are affected by Alzheimer’s, it’s currently the […]

The HEALEY ALS platform trial, the first study to test several therapy candidates for amyotrophic lateral sclerosis (ALS) simultaneously, has completed enrollment for at least two of its first three regimens. These include Clene Nanomedicine’s CNM-Au8 (NCT04414345) and Biohaven Pharmaceuticals’ verdiperstat (NCT04436510). The recruitment status for the other initial arm of the trial, UCB’s zilucoplan (NCT04436497), remains unclear, but all three regimens […]

OpRegen (Lineage Cell Therapeutics) has continued to show safety and efficacy in patients with dry age-related macular degeneration (AMD) with geographic atrophy (GA), according to recent data from a phase 1/2a clinical trial (NCT02286089).1,2 The data were presented at the American Academy of Ophthalmology (AAO) 2021 Meeting, November 12-15, by Michael S. Ip, MD, University of California Los Angeles, Doheny Eye […]